New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 21, 2018 - GlaxoSmithKline announced the FDA approval of Arnuity Ellipta (fluticasone furoate) for the maintenance treatment of asthma as prophylactic therapy in patients aged 5 years and older.
Download PDF
Return to publications
